Company profile for QSAM Biosciences

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

QSAM Biosciences, Inc. is a clinical stage company developing next-generation nuclear medicines for the treatment of cancer. Our lead product, Samarium-153 DOTMP (CycloSam®), is an advanced therapeutic radiopharmaceutical for multiple indications: treatment of primary bone cancer and metastatic bone cancers from the breast, prostate and lungs; bone marrow ablation; and reduction in external radiation.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
9442 N Capital of Texas Hwy, Austin, Texas 78759
Telephone
Telephone
5123434558
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

euroPLX 90 Lisbon

Not Confirmed

envelop Contact Supplier

euroPLX 90 Lisbon

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/telix-announces-proposed-acquisition-of-qsam-biosciences-and-its-lead-therapy-candidate-cyclosam-301986630.html

PR NEWSWIRE
13 Nov 2023

https://ir.qsambio.com/news-events/press-releases/detail/28/qsam-biosciences-reports-second-quarter-2022-financial

PRESS RELEASE
16 Aug 2022

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty